Appendices for Receipt of Selected Preventive Health Services for Women and Men of Reproductive Age — United States, 2011–2013
Surveillance Summaries / October 27, 2017 / 66 (20);1–31
Service | Recommendation |
Contraceptive services | Offer contraceptive services to all clients who wish to delay or prevent pregnancy. |
Pregnancy testing and counseling | Offer pregnancy testing and counseling to all clients seeking this service. |
Achieving pregnancy | Advise clients how to achieve pregnancy if they wish to become pregnant and are seeking this service. |
Basic infertility services | Offer basic infertility services to infertile clients (i.e., those who have failed to achieve pregnancy after 12 mos or longer of regular unprotected intercourse) seeking this service. Earlier assessment may be justified for clients with identified risk factors. |
Preconception health services | |
Folic acid*,† | All women planning or capable of pregnancy should be counseled about the need to take a daily supplement containing folic acid. |
IPV*,† | Screen all women of childbearing age for IPV and provide/refer to intervention services, as indicated. |
Alcohol and other drug use† | Screen clients for use of alcohol and other drugs and provide/refer for behavior counseling, as indicated. |
Tobacco use† | Screen clients for tobacco use and provide/refer for tobacco cessation interventions, as indicated; provide adolescents with interventions to prevent initiation of tobacco use. |
Immunizations | Screen for immunization status and provide/refer for immunization, as indicated by ACIP: influenza (annually); tetanus (once every 10 yrs); and HPV and hepatitis B (one-time receipt of vaccine series). |
Depression | Screen all clients for depression when staff-assisted depression care supports are in place to ensure accurate diagnosis, effective treatment, and follow-up. USPSTF notes that the optimum interval for screening for depression is unknown; however, they suggest that a pragmatic approach might be to screen all adults who have not been screened previously and to use clinical judgment in consideration of risk factors, comorbid conditions, and life events to determine whether additional screening of high-risk patients is warranted. |
BMI† | Assess client’s height, weight, and BMI and provide/refer adults with obesity for intensive counseling and behavioral interventions. |
Blood pressure | At the time QFP was published, the USPSTF recommendation was to screen persons with blood pressure <120/80 mm Hg routinely. For adults who are prehypertensive (i.e., 120–130 mm Hg/80–89 mm Hg), the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure recommends annual screening. AAP recommends annual screening for adolescents. In 2015, USPSTF updated its recommendation on blood pressure screening to indicate that adults at increased risk (i.e., black, with high normal blood pressure, with obesity or overweight, or aged >40 yrs) should be screened every year, while persons at low risk (aged 18–39 yrs with no risk factors) should be screened every 3–5 yrs. |
Diabetes | At the time QFP was published, the USPSTF recommendation was to screen for type 2 diabetes in asymptomatic adults with sustained blood pressure (either treated or untreated) >135/80 mm Hg. In 2015, USPSTF changed its recommendations to indicate adults aged 40–70 yrs with obesity or overweight should be screened for type 2 diabetes. USPSTF notes that evidence on the optimal rescreening interval for adults with an initial normal glucose test result is limited; however, rescreening every 3 yrs might be a reasonable approach for adults with normal blood glucose levels. |
STD services | |
Chlamydia | At the time QFP was published, the CDC recommendation was to screen annually for chlamydia infection all sexually active young females aged ≤25 yrs and among sexually active women aged >25 yrs with risk factors. Screening of male clients can be considered at sites with high prevalence of chlamydia infection and MSM. Recommendations are to provide/refer for treatment, as indicated. In 2015, CDC STD guidelines changed the age for screening all sexually active young women from ≤25 yrs to <25 yrs. Recommendations for women above this age with additional risk factors and male clients remain the same. |
Gonorrhea | Screen all women at risk for gonorrhea infection annually, including women aged <25 yrs. Screen MSM clients. Provide/refer for treatment, as indicated. |
Syphilis | Screen persons at risk for syphilis infection, including MSM, commercial sex workers, persons who exchange sex for drugs, persons in adult correctional facilities, and persons living in communities with high prevalence of syphilis. |
HIV/AIDS | Screen all clients aged 13–64 yrs for HIV/AIDS on a routine basis and rescreen all persons at high risk for HIV infection annually. Refer for care, as indicated. |
Hepatitis C | Provide one-time testing for hepatitis C infection for persons born during 1945–1965 and routine screening for persons at high risk for hepatitis C infection. Persons with HIV infection should be tested at least annually for hepatitis C infection. Provide/refer for treatment, as indicated. |
Related preventive health | |
Cervical cytology* | Screen women aged 21–65 yrs with cervical cytology (Pap smear) every 3 yrs or women aged 30–65 yrs with a combination of cytology and HPV testing every 5 yrs. Refer for further diagnosis and treatment, as indicated. |
Breast cancer screening* | Screen women aged 50–74 yrs biennially with mammogram; women aged <50 yrs can be considered if other conditions support providing the service. Refer for further diagnosis and treatment, as indicated. |
Outcome | Total (15–44 yrs) | 15–19 yrs | 20–24 yrs | 25–29 yrs | 30–34 yrs | 35–39 yrs | 40–44 yrs | |
Unintended pregnancies, 2011*,† | ||||||||
No. of unintended pregnancies (in 1,000s) | 2,779§ | 430 | 878 | 691 | 444 | 328¶ | ||
Unintended pregnancy (rate per 1,000 population)** | 45§ | 41 | 81 | 66 | 43 | 16¶ | ||
Pregnancies unintended (%) | 45§ | 75 | 59 | 42 | 31 | 34¶ | ||
Teen births, 2015†† | ||||||||
No. of teen births (in 1,000s) | N/A | 230 | N/A | N/A | N/A | N/A | N/A | |
Teen births (rate per 1,000 population)§§ | N/A | 22.3 | N/A | N/A | N/A | N/A | N/A | |
Teen births that are repeat births (%)¶¶ | N/A | 16.7 | N/A | N/A | N/A | N/A | N/A | |
Birth spacing, 2014*** | ||||||||
Singleton births conceived <18 mos after previous live birth (%) | 28.9††† | 22.4§§§ | 27.1 | 29.3 | 34.9 | 44.1¶ | ||
Infant health, 2015†† | ||||||||
Births that are preterm (%)¶¶¶ | 9.6††† | 9.9§§§ | 9.3 | 8.9 | 9.4 | 11.1 | 13.7 | |
Births with low birth weight (%)**** | 8.1††† | 9.5§§§ | 8.4 | 7.5 | 7.5 | 8.7 | 10.8 | |
Infertility, 2011–2013††††, §§§§ | ||||||||
Married and cohabiting women (% [95% CI]) | 6.3 (4.9–7.7) | —¶¶¶¶ | 4.9 (1.3–8.5) | 5.5 (2.6–8.5) | 4.2 (2.4–6.0) | 8.5 (4.6–12.3) | 8.3 (5.5–11.1) | |
Obesity, 2011–2012***** | ||||||||
Overweight women (% [95% CI])††††† | 25.2 (21.4–29.1) | 14.9 (9.7–20.0) | 21.7 (14.2–29.3) | 29.5 (25.0–33.9)§§§§§ | 28.3 (22.4–34.2)¶¶¶¶¶ | |||
Obese women (% [95% CI])††††† | 30.2 (27.1–33.4) | 16.4 (10.0–22.9) | 26.9 (18.3–35.5) | 34.4 (29.4–39.4)§§§§§ | 34.9 (29.9–39.9)¶¶¶¶¶ | |||
Hypertension, 2011–2012***** | ||||||||
Women with high blood pressure or medication for high blood pressure (% [95% CI])****** | 8.8 (6.8–10.7) | — | — | 6.4 (4.3–8.5)§§§§§ | 19.6 (15.0–24.2)¶¶¶¶¶ | |||
Diabetes, 2011–1012***** | ||||||||
Women ever told by health care professional they had diabetes (% [95% CI]s | 2.5 (1.7–3.4) | — | — | 1.2 (0.6–1.8)§§§§§ | 5.9 (3.7–8.2)¶¶¶¶¶ | |||
Diagnoses of HIV infection, 2014 estimated,†††††† both sexes | ||||||||
No. of diagnoses of HIV infection | 32,931 | 1,854 | 7,983 | 7,963 | 6,093 | 4,750 | 4,288 | |
Rate of diagnoses of HIV infection (per 100,000 population) | 13.9§§§§§§ | 8.7 | 34.4 | 35.8 | 28.0 | 23.5 | 20.6 | |
Diagnoses of HIV infection, 2014 estimated,†††††† males | ||||||||
No. of diagnoses of HIV infection | 27,371¶¶¶¶¶¶ | 1,505 | 7,083 | 6,853 | 4,970 | 3,659 | 3,301 | |
Diagnoses of HIV infection, 2014 estimated,†††††† females | ||||||||
No. of diagnoses of HIV infection | 5,561 | 349 | 901 | 1,110 | 1,123 | 1,091 | 987 | |
Diagnoses of AIDS, 2014 estimated,******* noncumulative, both sexes | ||||||||
No. of diagnoses of AIDS | 12,255 | 233 | 1,485 | 2,555 | 2,641 | 2,615 | 2,726 | |
Rate of diagnoses of AIDS (per 100,000 population) | 6.6§§§§§§ | 1.1 | 6.4 | 11.5 | 12.1 | 13.0 | 13.1 | |
Diagnoses of AIDS, 2014 estimated,¶¶¶¶¶¶ noncumulative, males | ||||||||
No. of diagnoses of AIDS | 9,334 | 166 | 1,236 | 2,090 | 2,013 | 1,878 | 1,951 | |
Diagnoses of AIDS, 2014 estimated,¶¶¶¶¶¶ noncumulative, females | ||||||||
No. of diagnoses of AIDS | 2,922 | 68 | 249 | 465 | 628 | 737 | 775 | |
STDs, 2014, number and rate, women******* | ||||||||
No. of chlamydia cases reported | 981,230 | 303,294 | 405,876 | 161,793 | 67,060 | 29,545 | 13,662 | |
Chlamydia cases reported per 100,000 women | 627.2††† | 2,941.0 | 3,651.1 | 1,523.4 | 633.7 | 300.9 | 130.3 | |
No. of gonorrhea cases reported | 156,589 | 44,399 | 59,329 | 28,899 | 13,988 | 6,654 | 3,320 | |
Gonorrhea cases reported per 100,000 women | 101.3††† | 430.5 | 533.7 | 272.1 | 132.2 | 67.8 | 31.7 | |
No. of syphilis cases reported | 1,654 | 262 | 503 | 361 | 248 | 177 | 103 | |
Syphilis cases reported per 100,000 women | 1.1††† | 2.5 | 4.5 | 3.4 | 2.3 | 1.8 | 1.0 | |
STDs, 2014, number and rate, men******* | ||||||||
No. of chlamydia cases reported | 412,036 | 77,908 | 159,804 | 91,729 | 45,990 | 22,894 | 13,711 | |
Chlamydia cases reported per 100,000 men | 278.4††††††† | 718.3 | 1,368.3 | 837.0 | 430.6 | 234.0 | 132.3 | |
No. of gonorrhea cases reported | 169,124 | 23,981 | 56,714 | 40,602 | 24,349 | 14,129 | 9,349 | |
Gonorrhea cases reported per 100,000 men | 120.1††††††† | 221.1 | 485.6 | 370.5 | 228.0 | 144.4 | 90.2 | |
No. of syphilis cases reported | 14,277 | 761 | 3,632 | 3,727 | 2,635 | 1,868 | 1,654 | |
Syphilis cases reported per 100,000 men | 11.7††††††† | 7.0 | 31.1 | 34.0 | 24.7 | 19.1 | 16.0 |
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of
Health and Human Services.
References to non-CDC sites on the Internet are
provided as a service to MMWR readers and do not constitute or imply
endorsement of these organizations or their programs by CDC or the U.S.
Department of Health and Human Services. CDC is not responsible for the content
of pages found at these sites. URL addresses listed in MMWR were current as of
the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.